Cigna Holding Co (CI) Shares Bought by Aspiriant LLC

Share on StockTwits

Aspiriant LLC raised its holdings in shares of Cigna Holding Co (NYSE:CI) by 112.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,128 shares of the health services provider’s stock after acquiring an additional 1,128 shares during the quarter. Aspiriant LLC’s holdings in Cigna were worth $408,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in CI. Private Ocean LLC purchased a new position in Cigna during the 4th quarter valued at about $26,000. Litman Gregory Asset Management LLC acquired a new stake in shares of Cigna during the 4th quarter valued at about $30,000. Valeo Financial Advisors LLC lifted its holdings in shares of Cigna by 216.4% during the 4th quarter. Valeo Financial Advisors LLC now owns 174 shares of the health services provider’s stock valued at $33,000 after buying an additional 119 shares during the last quarter. Versant Capital Management Inc lifted its holdings in shares of Cigna by 73.1% during the 4th quarter. Versant Capital Management Inc now owns 180 shares of the health services provider’s stock valued at $34,000 after buying an additional 76 shares during the last quarter. Finally, Regal Wealth Group Inc. acquired a new stake in shares of Cigna during the 4th quarter valued at about $35,000. 93.44% of the stock is currently owned by institutional investors.

In related news, Director John Partridge sold 1,000 shares of the business’s stock in a transaction that occurred on Thursday, February 7th. The stock was sold at an average price of $184.43, for a total value of $184,430.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Michael W. Triplett sold 9,148 shares of the business’s stock in a transaction that occurred on Monday, February 11th. The stock was sold at an average price of $181.01, for a total value of $1,655,879.48. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 10,349 shares of company stock valued at $1,882,688. Corporate insiders own 1.10% of the company’s stock.

Several equities research analysts have recently issued reports on the company. Leerink Swann lifted their price target on Cigna from $250.00 to $260.00 and gave the company an “outperform” rating in a report on Monday, November 19th. Raymond James upgraded Cigna from a “market perform” rating to an “outperform” rating and set a $187.17 price target for the company in a report on Thursday, January 3rd. ValuEngine upgraded Cigna from a “sell” rating to a “hold” rating in a report on Thursday, January 3rd. Edward Jones assumed coverage on Cigna in a report on Monday, December 24th. They set a “buy” rating and a $181.30 price target for the company. Finally, Zacks Investment Research upgraded Cigna from a “hold” rating to a “buy” rating and set a $208.00 price target for the company in a report on Friday, January 4th. Four equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Cigna currently has an average rating of “Buy” and an average price target of $229.09.

CI opened at $188.80 on Thursday. Cigna Holding Co has a twelve month low of $163.02 and a twelve month high of $226.60. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.42 and a quick ratio of 0.98. The company has a market capitalization of $45.34 billion, a P/E ratio of 13.28, a P/E/G ratio of 0.90 and a beta of 0.72.

Cigna (NYSE:CI) last posted its earnings results on Friday, February 1st. The health services provider reported $2.46 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $2.53 by ($0.07). Cigna had a return on equity of 16.64% and a net margin of 5.42%. The company had revenue of $13.75 billion during the quarter, compared to analyst estimates of $11.38 billion. During the same quarter last year, the firm posted $1.94 earnings per share. The firm’s revenue for the quarter was up 29.3% compared to the same quarter last year. Equities analysts expect that Cigna Holding Co will post 16.4 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Cigna Holding Co (CI) Shares Bought by Aspiriant LLC” was originally reported by Week Herald and is the sole property of of Week Herald. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The original version of this piece of content can be read at https://weekherald.com/2019/02/14/cigna-holding-co-ci-shares-bought-by-aspiriant-llc.html.

About Cigna

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Featured Article: Hedge Funds – Risk or Reward?

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply